The B & T Cell-Mediated Autoimmune Disease Drug Development Summit is dedicated to the definitive industry forum for drug developers investing in immune modulation strategies in autoimmune diseases.
The B & T Cell-Mediated Autoimmune Disease Drug Development Summit covers topics such as:
- T-Cell Interactions & Nanoparticle-Based Interactions for Immune Tolerance
- Harnessing Autoantibody Signatures and Mapping Out the B&T Cell-Mediated Autoimmune Disease Landscape
- Translating Therapeutics into the Clinic: Autoimmune Disease Biomarkers & Clinical Trial Considerations
- Comparing the Efficacy of Small Molecule Targeting on Signaling Pathways & their Impact on Autoimmune Diseases
- Revolutionizing Emerging Therapeutics & their Autoimmune Disease Applications
- Investigating the Opportunities & Challenges of Autoimmune Disease Models
- Incorporating Antigen-Specific & PROTAC/Degrader Approaches to Target Autoimmune Disease
